According to Ampio Pharmaceuticals's latest financial reports the company's total liabilities are $2.37 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $1.79 M | -84.41% |
2021-12-31 | $11.54 M | 115.08% |
2020-12-31 | $5.36 M | -29% |
2019-12-31 | $7.55 M | -14.06% |
2018-12-31 | $8.79 M | -82.23% |
2017-12-31 | $49.49 M | 610.93% |
2016-12-31 | $6.96 M | -44.27% |
2015-12-31 | $12.49 M | 159.71% |
2014-12-31 | $4.8 M | 71.54% |
2013-12-31 | $2.8 M | 39% |
2012-12-31 | $2.01 M | 17.09% |
2011-12-31 | $1.72 M | -63.7% |
2010-12-31 | $4.74 M | 1239.72% |
2009-12-31 | $0.35 M | 361.26% |
2008-12-31 | $0.07 M | 75.62% |
2007-12-31 | $0.04 M | 331.19% |
2006-12-31 | $0.01 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 4,157,475.76% | ๐บ๐ธ USA |
Pfizer PFE | $137.21 B | 5,774,857.91% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $34.38 B | 1,447,164.31% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $7.10 B | 299,020.37% | ๐บ๐ธ USA |
Rigel Pharmaceuticals RIGL | $0.14 B | 6,039.27% | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | $0.53 B | 22,609.26% | ๐บ๐ธ USA |